Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Puyraimond, A.
	Articles by Menashi, S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Puyraimond, A.
	Articles by Menashi, S.


Social Bookmarking

	What's this?

Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P. and Werb, Z (1996). Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122, 1723-1736.[Abstract]

Angel, P. and Karin, M (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.[Medline]

Bernhard, E. J., Gruber, S. B. and Muschel, R. J (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Nat. Acad. Sci. USA 91, 4293-4297.[Abstract/Free Full Text]

Chambers, A. F. and Matrisian, L. M (1997). Changing views of the role of matrix matalloproteinases in metastasis. J. Nat. Canc. Inst 89, 1260-1270.[Abstract/Free Full Text]

Chiu, R., Angel, P. and Karin, M (1989). Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59, 979-986.[Medline]

Crawford, H. C. and Matrisian, L. M (1996). Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 20-37.[Medline]

Desrivieres, S., Lu, H., Peyri, N., Soria, C., Legrand, Y. and Menashi, S (1993). Activation of the 92 kDa type IV collagenase by tissue kallikrein. J. Cell. Physiol 157, 587-593.[Medline]

Fini, M. E., Bartlett, J. D., Matsubara, M., Rinehart, W. B., Mody, M. K.,Girard, M. T. and Rainville, M (1994). The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J. Biol. Chem 269, 28620-28628.[Abstract/Free Full Text]

Fowlkes, J. L., Enghild, J. J., Suzuki, K. and Nagase, H (1994). Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem 269, 25742-25746.[Abstract/Free Full Text]

Fridman, R., Toth, M., Pena, D. and Mobashery, S (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55, 2548-2555.[Abstract/Free Full Text]

Galardy, R. E., Grobelny, D., Foellmer, H. G. and Fernandez, L. A (1994). Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res 54, 4715-4718.[Abstract/Free Full Text]

Goodman, S. L., Vollmers, H. P. and Birchmeier, W (1985). Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins. Cell 41, 1029-1038.[Medline]

Hanahan, D. and Folkman, J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.[Medline]

Heimark, R. L., Twardzik, D. R. and Schwartz, S. M (1986). Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233, 1078-1080.[Abstract/Free Full Text]

Himelstein, B. P., Canete, S. R., Bernhard, E. J., Dilks, D. W. and Muschel, R. J (1994). Metalloproteinases in tumor progression: the contribution of MMP-9. Inv. Metast 14, 246-258.[Medline]

Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R. and Weiss, S. J (1998). Matrix metalloproteinases regulate neovascularisation by acting as pericellular fibrinolysins. Cell 95, 365-377.[Medline]

Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58, 1048-1051.[Abstract/Free Full Text]

Johnson, M. D., Kim, H. R., Chesler, L., Tsao, W. G., Bouck, N. and Polverini, P. J (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol 160, 194-202.[Medline]

Kerr, L. D., Miller, D. B. and Matrisian, L. M (1990). TGF-1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61, 267-278.[Medline]

Kretzschmar, M. and Massague, J (1998). SMADs: mediators and regulators of TGF-signaling. Curr. Opin. Genet. Dev 8, 103-111.[Medline]

Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A. and Vlodavsky, I (1996). Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Nat. Acad. Sci. USA 93, 7069-7074.[Abstract/Free Full Text]

Logan, S. K., Garabedian, M. J., Campbell, C. E. and Werb, Z (1996). Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem 271, 774-782.[Abstract/Free Full Text]

Madri, J. A., Pratt, B. M. and Tucker, A. M (1988). Phenotypic modulation of endothelial cells by transforming growth factor-depends upon the composition and organization of the extracellular matrix. J. Cell Biol 106, 1375-1384.[Abstract/Free Full Text]

Matrisian, L. M (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6, 121-125.[Medline]

Matrisian, L. M., Ganser, G. L., Kerr, L. D., Pelton, R. W. and Wood, L. D (1992). Negative regulation of gene expression by TGF-. Mol. Reprod. Dev 32, 111-120.[Medline]

Mauviel, A., Chen, Y. Q., Dong, W., Evans, C. H. and Uitto, J (1993). Transcriptional interactions of transforming growth factor-with pro-inflammatory cytokines. Curr. Biol 3, 822-831.

Mauviel, A., Chung, K. Y., Agarwal, A., Tamai, K. and Uitto, J (1996). Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-in fibroblasts and keratinocytes. J. Biol. Chem 271, 10917-10923.[Abstract/Free Full Text]

Montesano, R. and Orci, L (1985). Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42, 469-477.[Medline]

Montesano, R. and Orci, L (1987). Phorbol esters induce angiogenesis invitro from large-vessel endothelial cells. J. Cell. Physiol 130, 284-291.[Medline]

Muller, G., Behrens, J., Nussbaumer, U., Bohlen, P. and Birchmeier, W (1987). Inhibitory action of transforming growth factoron endothelial cells. Proc. Nat. Acad. Sci. USA 84, 5600-5604.[Abstract/Free Full Text]

Murphy, A. N., Unsworth, E. J. and Stetler-Stevenson, W. G (1993). Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol 157, 351-358.[Medline]

Murphy, G., Cockett, M. I., Ward, R. V. and Docherty, A. J (1991). Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and-2 and punctuated metalloproteinase (PUMP). Biochem. J 277, 277-279.

Ochieng, J., Fridman, R., Nangia-Makker, P., Kleiner, D. E., Liotta, L. A., Stetler-Stevenson, W. G. and Raz, A (1994). Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9. Biochemistry 33, 14109-14114.[Medline]

Oliver, G. W., Leferson, J. D., Stetler-Stevenson, W. G. and Kleiner, D. E (1997). Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem 244, 161-166.[Medline]

Olson, M. W., Gervasi, D. C., Mobashery, S. and Fridman, R (1997). Kinetic analysis of the binding of human matrix metalloproteinase-2 and- 9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem 272, 29975-29983.[Abstract/Free Full Text]

Overall, C. M., Wrana, J. L. and Sodek, J (1991). Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem 266, 14064-14071.[Abstract/Free Full Text]

Patterson, B. C. and Sang, Q. A (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem 272, 28823-28825.[Abstract/Free Full Text]

Pepper, M. S., Belin, D., Montesano, R., Orci, L. and Vassalli, J. D (1990). Transforming growth factor-1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol 111, 743-755.[Abstract/Free Full Text]

Pepper, M. S., Vassalli, J. D., Orci, L. and Montesano, R (1993). Biphasic effect of transforming growth factor-1 on in vitro angiogenesis. Exp. Cell Res 204, 356-363.[Medline]

Pfarr, C. M., Mechta, F., Spyrou, G., Lallemand, D., Carillo, S. and Yaniv, M (1994). Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76, 747-755.[Medline]

Salo, T., Lyons, J. G., Rahemtulla, F., Birkedal-Hansen, H. and Larjava, H (1991). Transforming growth factor-1 up-regulates type IV collagenaseexpression in cultured human keratinocytes. J. Biol. Chem 266, 11436-11441.[Abstract/Free Full Text]

Sato, H. and Seiki, M (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405.[Medline]

Schutte, J., Viallet, J., Nau, M., Segal, S., Fedorko, J. and Minna, J (1989). jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59, 987-997.[Medline]

Shimizu, S., Nishikawa, Y., Kuroda, K., Takagi, S., Kozaki, K., Hyuga, S., Saga, S. and Matsuyama, M (1996). Involvement of transforming growth factor1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res 56, 3366-3367.[Abstract/Free Full Text]

Stetler-Stevenson, W. G (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metast. Rev 9, 289-303.[Medline]

Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D. and Giavazzi, R (1995). Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Nat. Cancer Inst 87, 293-298.[Abstract/Free Full Text]

Uria, J. A., Jimenez, M. G., Balbin, M., Freije, J. M. P. and Lopez-Otin, C (1998). Differential effects of transforming growth factor-on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J. Biol. Chem 273, 9769-9777.[Abstract/Free Full Text]

Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.[Medline]

Wang, W., Zhou, G., Hu, M. C. T., Yao, Z. and Tan, T. H (1997). Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor(TGF- )-activated kinase (TAK1), a kinase mediator of TGFsignal transduction. J. Biol. Chem 272, 22771-22775.[Abstract/Free Full Text]

Welch, D. R., Fabra, A. and Nakajima, M (1990). Transforming growth factorstimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Nat. Acad. Sci. USA 87, 7678-7682.[Abstract/Free Full Text]

Yang, E. Y. and Moses, H. L (1990). Transforming growth factor1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol 111, 731-741.[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

J. D. Easterbrook and S. L. Klein
Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats
J. Gen. Virol., November 1, 2008; 89(11): 2723 - 2730.
[Abstract] [Full Text] [PDF]

Y. Greenberg, M. King, W. B. Kiosses, K. Ewalt, X. Yang, P. Schimmel, J. S. Reader, and E. Tzima
The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells
FASEB J, May 1, 2008; 22(5): 1597 - 1605.
[Abstract] [Full Text] [PDF]

J. M. Barnett, G. W. McCollum, J. A. Fowler, J. J.-W. Duan, J. D. Kay, R.-Q. Liu, D. P. Bingaman, and J. S. Penn
Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 907 - 915.
[Abstract] [Full Text] [PDF]

M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al.
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H232 - H239.
[Abstract] [Full Text] [PDF]

S. Cambier, S. Gline, D. Mu, R. Collins, J. Araya, G. Dolganov, S. Einheber, N. Boudreau, and S. L. Nishimura
Integrin {alpha}v{beta}8-Mediated Activation of Transforming Growth Factor-{beta} by Perivascular Astrocytes: An Angiogenic Control Switch
Am. J. Pathol., June 1, 2005; 166(6): 1883 - 1894.
[Abstract] [Full Text] [PDF]

S. G. Park, H. J. Kim, Y. H. Min, E.-C. Choi, Y. K. Shin, B.-J. Park, S. W. Lee, and S. Kim
From The Cover: Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response
PNAS, May 3, 2005; 102(18): 6356 - 6361.
[Abstract] [Full Text] [PDF]

B. Bedogni, M. S. O'Neill, S. M. Welford, D. M. Bouley, A. J. Giaccia, N. C. Denko, and M. B. Powell
Topical Treatment with Inhibitors of the Phosphatidylinositol 3'-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice
Cancer Res., April 1, 2004; 64(7): 2552 - 2560.
[Abstract] [Full Text] [PDF]

J. S. Penn and V. S. Rajaratnam
Inhibition of Retinal Neovascularization by Intravitreal Injection of Human rPAI-1 in a Rat Model of Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5423 - 5429.
[Abstract] [Full Text] [PDF]

N. Chandrasekar, S. Mohanam, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and Jasti. S. Rao
Glial Cell-induced Endothelial Morphogenesis Is Inhibited by Interfering with Extracellular Signal-regulated Kinase Signaling
Clin. Cancer Res., June 1, 2003; 9(6): 2342 - 2349.
[Abstract] [Full Text] [PDF]

S. G. Park, Y.-S. Kang, Y. H. Ahn, S. H. Lee, K.-R. Kim, K.-W. Kim, G. Y. Koh, Y.-G. Ko, and S. Kim
Dose-dependent Biphasic Activity of tRNA Synthetase-associating Factor, p43, in Angiogenesis
J. Biol. Chem., November 15, 2002; 277(47): 45243 - 45248.
[Abstract] [Full Text] [PDF]

D. Salani, G. Taraboletti, L. Rosano, V. Di Castro, P. Borsotti, R. Giavazzi, and A. Bagnato
Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
Am. J. Pathol., November 1, 2000; 157(5): 1703 - 1711.
[Abstract] [Full Text] [PDF]

R. M. Korah, V. Sysounthone, Y. Golowa, and R. Wieder
Basic Fibroblast Growth Factor Confers a Less Malignant Phenotype in MDA-MB-231 Human Breast Cancer Cells
Cancer Res., February 1, 2000; 60(3): 733 - 740.
[Abstract] [Full Text]

E Genersch, K Hayess, Y Neuenfeld, and H Haller
Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways
J. Cell Sci., January 12, 2000; 113(23): 4319 - 4330.
[Abstract] [PDF]

M. L. Lindsey, J. Gannon, M. Aikawa, F. J. Schoen, E. Rabkin, L. Lopresti-Morrow, J. Crawford, S. Black, P. Libby, P. G. Mitchell, et al.
Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction
Circulation, February 12, 2002; 105(6): 753 - 758.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Puyraimond, A.

Articles by Menashi, S.

Search for Related Content

PubMed

PubMed Citation

Articles by Puyraimond, A.

Articles by Menashi, S.

Social Bookmarking

What's this?

				Y. Greenberg, M. King, W. B. Kiosses, K. Ewalt, X. Yang, P. Schimmel, J. S. Reader, and E. Tzima The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells FASEB J, May 1, 2008; 22(5): 1597 - 1605. [Abstract] [Full Text] [PDF]

				J. M. Barnett, G. W. McCollum, J. A. Fowler, J. J.-W. Duan, J. D. Kay, R.-Q. Liu, D. P. Bingaman, and J. S. Penn Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 907 - 915. [Abstract] [Full Text] [PDF]

				M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H232 - H239. [Abstract] [Full Text] [PDF]

				S. Cambier, S. Gline, D. Mu, R. Collins, J. Araya, G. Dolganov, S. Einheber, N. Boudreau, and S. L. Nishimura Integrin {alpha}v{beta}8-Mediated Activation of Transforming Growth Factor-{beta} by Perivascular Astrocytes: An Angiogenic Control Switch Am. J. Pathol., June 1, 2005; 166(6): 1883 - 1894. [Abstract] [Full Text] [PDF]

				S. G. Park, H. J. Kim, Y. H. Min, E.-C. Choi, Y. K. Shin, B.-J. Park, S. W. Lee, and S. Kim From The Cover: Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response PNAS, May 3, 2005; 102(18): 6356 - 6361. [Abstract] [Full Text] [PDF]

				B. Bedogni, M. S. O'Neill, S. M. Welford, D. M. Bouley, A. J. Giaccia, N. C. Denko, and M. B. Powell Topical Treatment with Inhibitors of the Phosphatidylinositol 3'-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice Cancer Res., April 1, 2004; 64(7): 2552 - 2560. [Abstract] [Full Text] [PDF]

				J. S. Penn and V. S. Rajaratnam Inhibition of Retinal Neovascularization by Intravitreal Injection of Human rPAI-1 in a Rat Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5423 - 5429. [Abstract] [Full Text] [PDF]

				N. Chandrasekar, S. Mohanam, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and Jasti. S. Rao Glial Cell-induced Endothelial Morphogenesis Is Inhibited by Interfering with Extracellular Signal-regulated Kinase Signaling Clin. Cancer Res., June 1, 2003; 9(6): 2342 - 2349. [Abstract] [Full Text] [PDF]

				S. G. Park, Y.-S. Kang, Y. H. Ahn, S. H. Lee, K.-R. Kim, K.-W. Kim, G. Y. Koh, Y.-G. Ko, and S. Kim Dose-dependent Biphasic Activity of tRNA Synthetase-associating Factor, p43, in Angiogenesis J. Biol. Chem., November 15, 2002; 277(47): 45243 - 45248. [Abstract] [Full Text] [PDF]

				D. Salani, G. Taraboletti, L. Rosano, V. Di Castro, P. Borsotti, R. Giavazzi, and A. Bagnato Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo Am. J. Pathol., November 1, 2000; 157(5): 1703 - 1711. [Abstract] [Full Text] [PDF]

				R. M. Korah, V. Sysounthone, Y. Golowa, and R. Wieder Basic Fibroblast Growth Factor Confers a Less Malignant Phenotype in MDA-MB-231 Human Breast Cancer Cells Cancer Res., February 1, 2000; 60(3): 733 - 740. [Abstract] [Full Text]

				E Genersch, K Hayess, Y Neuenfeld, and H Haller Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways J. Cell Sci., January 12, 2000; 113(23): 4319 - 4330. [Abstract] [PDF]

				M. L. Lindsey, J. Gannon, M. Aikawa, F. J. Schoen, E. Rabkin, L. Lopresti-Morrow, J. Crawford, S. Black, P. Libby, P. G. Mitchell, et al. Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction Circulation, February 12, 2002; 105(6): 753 - 758. [Abstract] [Full Text] [PDF]